Shelton Capital Management Crispr Therapeutics Ag Transaction History

Shelton Capital Management

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$39.19 - $65.67 $2.23 Million - $3.74 Million	-57,000 Reduced 43.23%	74,850 $3.04 Million
Q3 2022 Nov 14, 2022	SELL	$61.1 - $83.78 $1.11 Million - $1.52 Million	-18,150 Reduced 12.1%	131,850 $8.62 Million
Q4 2021 Feb 11, 2022	BUY	$70.09 - $111.29 $1.96 Million - $3.12 Million	28,000 Added 22.95%	150,000 $11.4 Million
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $3.75 Million - $5.33 Million	34,000 Added 38.64%	122,000 $13.7 Million
Q2 2021 Aug 12, 2021	BUY	$100.84 - $161.89 $806,720 - $1.3 Million	8,000 Added 10.0%	88,000 $14.2 Million
Q1 2021 May 14, 2021	BUY	$110.72 - $210.04 $4.73 Million - $8.97 Million	42,700 Added 114.48%	80,000 $9.75 Million
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $422,251 - $918,119	5,300 Added 16.56%	37,300 $5.71 Million
Q1 2020 May 13, 2020	BUY	$33.68 - $62.53 $303,120 - $562,770	9,000 Added 39.13%	32,000 $1.36 Million
Q4 2019 Feb 11, 2020	BUY	$36.68 - $73.13 $36,680 - $73,130	1,000 Added 4.55%	23,000 $1.4 Million
Q2 2019 Aug 14, 2019	BUY	$35.45 - $48.2 $757,991 - $1.03 Million	21,382 Added 3459.87%	22,000 $1.04 Million
Q1 2019 May 10, 2019	SELL	$28.02 - $40.87 $341,339 - $497,878	-12,182 Reduced 95.17%	618 $17.3 Million
Q4 2018 Jan 31, 2019	BUY	$22.73 - $42.34 $120,469 - $224,402	5,300 Added 70.67%	12,800 $366,000
Q2 2018 Aug 10, 2018	BUY	$42.62 - $73.59 $319,650 - $551,925	7,500 New	7,500 $441,000

489

57.9M

1.09M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.16B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

Stay updated on Shelton Capital Management with notifications on news.